Nls Pharmaceutics Ltd (NLSP) has released an update.
NLS Pharmaceutics AG has reached an agreement with lender Ronald Hafner to extend the maturity date of their existing loan agreement to December 31, 2024. The terms of the original loan, signed on September 28, 2023, with an amendment on November 15, 2023, remain largely unchanged except for the extension. All legal matters related to this agreement will be governed by Swiss law and are under the jurisdiction of the courts in Zurich.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
